WuXi Chooses Philadelphia for New Cell Therapy Manufacturing Facility

SourceGEN (Genetic Engineering & Biotechnology News)
Date Published03/12/2015
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name WuXi PharmaTech
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Transplant
Year reshoring announced:2015
Year reshoring implemented or to be implemented:2015
Domestically, the work will be done:In-house
Country(ies) from which reshored:China
City reshored to:Philedelphia
State(s) reshored to:PA
If relevant, work nearshored to:-
Industry(ies):Other, Biotechnology
Product(s) reshoredcell therapy products
What domestic positive factors made reshoring more attractive?Manufacturing/engineering joint innovation (R&D)
Find Reshoring Articles